cardiovascularКардиоваскулярная терапия и профилактикаCardiovascular Therapy and Prevention1728-88002619-0125«SILICEA-POLIGRAF» LLCcardiovascular-1516Research ArticleМНЕНИЕ ПО ПРОБЛЕМЕOPINION ON A PROBLEMПериооперативное применение Р-адреноблокаторов и риск сердечно-сосудистых осложнений: все ли вопросы решены?Perioperative beta-adrenoblocker therapy and cardiovascular event risk: are all the problems solved?ЛопатинЮ. М.LopatinYu. M.

Заведующий кафедрой кардиологии с функциональной диагностикой ФУВ; заведующий отделом ишемической болезни сердца

lopatin@vlpost.ruВолгоградский государственный медицинский университет; Волгоградский областной кардиологический центрVolgograd State Medical University; Volgograd Region Cardiology Centre200920122009867176Copyright © Лопатин Ю.М., 20092009Лопатин Ю.М.Lopatin Y.M.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://cardiovascular.elpub.ru/jour/article/view/1516

Статья посвящена возможностям применения Р-адреноблокаторов в периоперационном периоде у больных с некардиальным хирургическим вмешательствам. Проанализированы результаты рандомизированных клинических испытаний POISE (2007) и DECREASE (1999-2009).

The paper focuses on beta-blocker potential in perioperative period among the patients undergoing non-cardiac surgery. The results of two randomised clinical trials, POISE (2007) and DECREASE (1999-2009), are analysed.

некардиальные хирургические вмешательствапериоперационный периодР-адреноблокаторыбисопрололnon-cardiac surgeryperioperative periodbeta-adrenoblockersbisoprololReferencesPOISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomized controlled trial. Lancet 2008; 371: 1839-47.POISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomized controlled trial. Lancet 2008; 371: 1839-47.Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2007; 116: e418-99.Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2007; 116: e418-99.Yang H, Raymer K, Butler R, et al. The effects of perioperative beta-blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J 2006; 152: 983-90.Yang H, Raymer K, Butler R, et al. The effects of perioperative beta-blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J 2006; 152: 983-90.Juul AB, Wetterslev J, Gluud C, et al. Effect of perioperative beta blockade in patients with diabetes undergoingmajor non-cardiac surgery: randomised placebo controlled, blinded multicentre trial. Br Med J 2006; 332: 1482.Juul AB, Wetterslev J, Gluud C, et al. Effect of perioperative beta blockade in patients with diabetes undergoingmajor non-cardiac surgery: randomised placebo controlled, blinded multicentre trial. Br Med J 2006; 332: 1482.Bangalore S, Wetterslev J, Pranesh Sh, et al. Perioperative p blockers in patients having non-cardiac surgery: a meta-analysis. Lancet 2008, D0I:10.1016/S0140-6736(08)61560-3.Bangalore S, Wetterslev J, Pranesh Sh, et al. Perioperative p blockers in patients having non-cardiac surgery: a meta-analysis. Lancet 2008, D0I:10.1016/S0140-6736(08)61560-3.Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 1999; 341: 1789-94.Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 1999; 341: 1789-94.Poldermans D, Boersma E, Bax JJ, et al., for the Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery. Eur Heart J 2001; 22: 1353-8.Poldermans D, Boersma E, Bax JJ, et al., for the Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery. Eur Heart J 2001; 22: 1353-8.Poldermans D, Bax JJ, Schouten O, et al. for the Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echo Study Group. Should Major Vascular Surgery Be Delayed Because of Preoperative Cardiac Testing in Intermediate-Risk Patients Receiving Beta-Blocker Therapy With Tight Heart Rate Control? JACC 2006; 48: 964-9.Poldermans D, Bax JJ, Schouten O, et al. for the Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echo Study Group. Should Major Vascular Surgery Be Delayed Because of Preoperative Cardiac Testing in Intermediate-Risk Patients Receiving Beta-Blocker Therapy With Tight Heart Rate Control? JACC 2006; 48: 964-9.Poldermans D, Schouten O, Benner R, et al. Fluvastatin XL Use Is Associated With Improved Cardiac Outcome After Major Vascular Surgery. Results From A Randomized Placebo Controlled Trial: Decrease III. Circulation 2008; 118: S792.Poldermans D, Schouten O, Benner R, et al. Fluvastatin XL Use Is Associated With Improved Cardiac Outcome After Major Vascular Surgery. Results From A Randomized Placebo Controlled Trial: Decrease III. Circulation 2008; 118: S792.Dunkelgrun M, Boersma E, Schouten O, et al. for The Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group Bisoprolol and Fluvastatin for the Reduction of Perioperative Cardiac Mortality and Myocardial Infarction in Intermediate-Risk Patients Undergoing Noncardiovascular Surgery. A Randomized Controlled Trial (DECREASE-IV). Ann Surg 2009; 249: 921-6.Dunkelgrun M, Boersma E, Schouten O, et al. for The Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group Bisoprolol and Fluvastatin for the Reduction of Perioperative Cardiac Mortality and Myocardial Infarction in Intermediate-Risk Patients Undergoing Noncardiovascular Surgery. A Randomized Controlled Trial (DECREASE-IV). Ann Surg 2009; 249: 921-6.

The authors declare that there are no conflicts of interest present.